Last CNY15.53 CNY
Change Today -0.16 / -1.02%
Volume 1.2M
As of 9:16 PM 12/17/14 All times are local (Market data is delayed by at least 15 minutes).

zhejiang huahai pharmaceut-a (600521) Snapshot

Open
CNY15.66
Previous Close
CNY15.69
Day High
CNY15.74
Day Low
CNY15.45
52 Week High
12/5/14 - CNY16.58
52 Week Low
04/29/14 - CNY9.78
Market Cap
12.2B
Average Volume 10 Days
15.3M
EPS TTM
CNY0.36
Shares Outstanding
785.7M
EX-Date
05/13/14
P/E TM
42.9x
Dividend
CNY0.20
Dividend Yield
1.29%
Current Stock Chart for ZHEJIANG HUAHAI PHARMACEUT-A (600521)

Related News

No related news articles were found.

zhejiang huahai pharmaceut-a (600521) Related Businessweek News

No Related Businessweek News Found

zhejiang huahai pharmaceut-a (600521) Details

Zhejiang Huahai Pharmaceutical Co., Ltd. manufactures and sells formulations, active pharmaceutical ingredients, and intermediates in China and internationally. It provides pril products, such as captopril, enalapril, and lisinopril. The company was founded in 1989 and is based in Linhai, China.

Founded in 1989

zhejiang huahai pharmaceut-a (600521) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

zhejiang huahai pharmaceut-a (600521) Key Developments

Zhejiang Huahai Pharmaceutical co Ltd(SHSE:600521) dropped from SSE 180 Index

Zhejiang Huahai Pharmaceutical co Ltd will be removed from the SSE 180 Index.

FDA Notifies Zhejiang Huahai Pharmaceutical Co Ltd for Approval of ANDA Paroxetine Hydrochloride Tablets

Zhejiang Huahai Pharmaceutical Co. Ltd. was recently notified by the FDA for approval of ANDA for Paroxetine Hydrochloride Tablets, whose reference listed drug developer is APOTEX TECHNOLOGIES, used for treating MDD. Thus, the Chinese drug maker can sell the drug in US from December 2014 as expected.

Zhejiang Huahai Pharmaceutical Co Ltd Reports Earnings Results for the First Three Quarters of 2014

Zhejiang Huahai Pharmaceutical co Ltd. reported earnings results for the first three quarters of 2014. For the period, the company reported basic earning per share of CNY 0.26 and weighted average return on net assets of 6.66%.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
600521:CH CNY15.53 CNY -0.16

600521 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 600521.
View Industry Companies
 

Industry Analysis

600521

Industry Average

Valuation 600521 Industry Range
Price/Earnings 42.7x
Price/Sales 5.1x
Price/Book 3.9x
Price/Cash Flow 45.0x
TEV/Sales 4.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ZHEJIANG HUAHAI PHARMACEUT-A, please visit www.huahaipharm.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.